Our flagship diagnostic portfolio addresses some of the most pressing and underdiagnosed health challenges in India...
Read More
BridgeInDx is addressing this gap by developing AI-based LFAs for common cancers in canines and felines...
Read More
For researchers and innovators, turning an idea into a viable product can be complex. BridgeInDx simplifies this journey...
Read More
We believe in the power of collaboration. BridgeInDx actively partners with academic institutions, incubators, and healthcare innovators...
Read More
We design and develop lateral flow assays
(LFAs) tests that are non-invasive, rapid, and supported by integration of different biomarkers into...
We support clinicians,
researchers, and innovators in turning ideas into reality. From feasibility studies and prototyping to regulatory
...
We actively scout for promising diagnostic concepts in academia,
incubators, and healthcare institutions. These ideas are carefully evaluated,...
We guide small and medium-sized diagnostic companies from Europé or
other parts of world that wish to launch their products in India. This...
Lung cancer remains one of the deadliest cancers due to late detection. BridgeInDx is building AI-powered tests that combine biomarker panels with...
Read More
Ovarian cancer is often called the “silent killer” because symptoms are vague and most women are diagnosed at advanced stages. We are working on...
Read More
Colorectal cancer is one of the fastest-growing cancers in India, with many cases going undiagnosed until late stages. BridgeInDx is developing...
Read More
We are developing urine-based rapid tests capable of detecting infections, hematuria, and bladder cancer risk factors. These tests provide quick and...
Read More